Abbott wins FDA panel vote for mitral valve repair system

03/21/2013 | Yahoo

A panel of FDA advisers has voted in favor of recommending approval for Abbott Laboratories' MitraClip system, saying its benefits surpassed the risks. The implantable device, available commercially in 30 countries, is used to treat leaky mitral heart valves in patients who are deemed at high risk for open-heart procedures.

View Full Article in:

Yahoo

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT